Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-25-322740

Chief Legal Officer sold 3,452 shares at $12.92 ($44,600)

From the SEC's structured data for this filing

Trades in this filing

Oltmans Curtis Gale · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Sale : show line 1 in the form −3,452 $12.92 $44,600 10,252 D
Open-market sales · 3,452 sh · avg $12.92 · $44,600
Loading xslF345X05/ownership.xml…